Literature DB >> 12611842

Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study.

Adam Wolkin1, Steven J Choi, Sandor Szilagyi, Michael Sanfilipo, John P Rotrosen, Kelvin O Lim.   

Abstract

OBJECTIVE: The purpose of this study was test the hypothesis that abnormalities of inferior frontal white matter are related to the negative symptoms of schizophrenia.
METHOD: Fractional anisotropy of white matter tracts in the prefrontal area of 10 schizophrenic patients was determined by diffusion tensor imaging. Patients were also assessed for severity of negative symptoms by using the Schedule for the Assessment of Negative Symptoms (SANS).
RESULTS: Inferior frontal white matter fractional anisotropy was significantly inversely correlated with the SANS global ratings of negative symptoms.
CONCLUSIONS: These data, while preliminary, suggest that impaired white matter integrity in the inferior frontal region may be associated with the severity of negative symptoms in schizophrenia.

Entities:  

Mesh:

Year:  2003        PMID: 12611842     DOI: 10.1176/appi.ajp.160.3.572

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  50 in total

1.  Evidence for white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Robert W McCarley; Martha E Shenton
Journal:  Curr Opin Psychiatry       Date:  2005-03       Impact factor: 4.741

Review 2.  MR diffusion tensor imaging: a window into white matter integrity of the working brain.

Authors:  Sandra Chanraud; Natalie Zahr; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychol Rev       Date:  2010-04-27       Impact factor: 7.444

3.  Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients.

Authors:  Majda M Thurnher; Mauricio Castillo; Alfred Stadler; Armin Rieger; Brigitte Schmid; Pia C Sundgren
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

4.  Cerebral white matter abnormalities and their associations with negative but not positive symptoms of schizophrenia.

Authors:  Takeshi Asami; Sang Hyuk Lee; Sylvain Bouix; Yogesh Rathi; Thomas J Whitford; Margaret Niznikiewicz; Paul Nestor; Robert W McCarley; Martha E Shenton; Marek Kubicki
Journal:  Psychiatry Res       Date:  2014-02-19       Impact factor: 3.222

5.  Effects of age on white matter integrity and negative symptoms in schizophrenia.

Authors:  Kelly Rowe Bijanki; Brendan Hodis; Vincent A Magnotta; Eugene Zeien; Nancy C Andreasen
Journal:  Schizophr Res       Date:  2014-06-20       Impact factor: 4.939

6.  Shared and distinct alterations of white matter tracts in remitted and nonremitted patients with schizophrenia.

Authors:  Jing-Ying Huang; Chih-Min Liu; Tzung-Jeng Hwang; Yu-Jen Chen; Yung-Chin Hsu; Hai-Gwo Hwu; Yi-Tin Lin; Ming-Hsien Hsieh; Chen-Chung Liu; Yi-Ling Chien; Wen-Yih Isaac Tseng
Journal:  Hum Brain Mapp       Date:  2018-01-28       Impact factor: 5.038

7.  White matter abnormalities in schizophrenia and schizotypal personality disorder.

Authors:  Marc S Lener; Edmund Wong; Cheuk Y Tang; William Byne; Kim E Goldstein; Nicholas J Blair; M Mehmet Haznedar; Antonia S New; Eran Chemerinski; King-Wai Chu; Liza S Rimsky; Larry J Siever; Harold W Koenigsberg; Erin A Hazlett
Journal:  Schizophr Bull       Date:  2014-06-23       Impact factor: 9.306

Review 8.  Diffusion MRI and its Role in Neuropsychology.

Authors:  Bryon A Mueller; Kelvin O Lim; Laura Hemmy; Jazmin Camchong
Journal:  Neuropsychol Rev       Date:  2015-08-09       Impact factor: 7.444

9.  Diffusion Imaging of White Matter In Schizophrenia: Progress and Future Directions.

Authors:  Katherine H Karlsgodt
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-05

10.  White matter alterations in deficit schizophrenia.

Authors:  Laura M Rowland; Elena A Spieker; Alan Francis; Peter B Barker; William T Carpenter; Robert W Buchanan
Journal:  Neuropsychopharmacology       Date:  2008-12-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.